German Alberto Venegas Esquivel

Dr. German Alberto Venegas Esquivel

Infectious disease, Hospital para el Niño, Toluca, México, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
EDElda Carolina Dávila
Elda Carolina Dávila
PhD María Guadalupe Berumen-LechugaPhD María Guadalupe Berumen-Lechuga
PhD María Guadalupe Berumen-Lechuga
Carlos José Molina PérezCarlos José Molina Pérez
Carlos José Molina Pérez
RJRodolfo Norberto Jiménez Juárez
Rodolfo Norberto Jiménez Juárez
ALAlfredo Leaños-Miranda
Alfredo Leaños-Miranda
GEGerman Alberto Venegas Esquivel
German Alberto Venegas Esquivel
Background: Antimicrobial resistance is a global health problem, due to morbidity, mortality, and healthcare costs. The misuse of antimicrobials is the main cause of antimicrobial resistance. The aim of this study was to report antimicrobial resistance and antibiotic consumption in a secondary care hospital in Mexico. Methods: Within a cross-sectional study, antimicrobial resistance data on ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) and antibiotic consumption from 2020 to 2022 were collected. Antimicrobial resistance was reported based on percentages of resistance and consumption was analyzed using the defined daily dose (DDD)/100 bed days and the AWaRe (Access, Surveillance, Reservation) antibiotic group. Results: Antibiotic consumption in 2020, 2021 and 2022 was 330, 175 and 175 DDD/100 beds day, respectively. The rate of ceftriaxone resistance in E. coli (n = 526) and K. pneumoniae (n = 80) was 76% and 69%, respectively, the rate of carbapenem resistance in A. baumannii (n = 168) and P. aeruginosa (n = 108) was 92% and 52%, respectively; the rate of oxacillin resistance in S. aureus (n = 208) was 27%; and the rate of vancomycin resistance in E. faecium (n = 68) was 47%. Conclusion: The reported results are congruent with global estimates of antibiotic resistance and consumption, providing an overview that could generate actions for antimicrobial optimization at the local and regional levels.

9 November 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
GEGerman Alberto Venegas Esquivel
German Alberto Venegas Esquivel
PhD María Guadalupe Berumen-LechugaPhD María Guadalupe Berumen-Lechuga
PhD María Guadalupe Berumen-Lechuga
Carlos José Molina PérezCarlos José Molina Pérez
Carlos José Molina Pérez
RJRodolfo Norberto Jimenez-Juarez
Rodolfo Norberto Jimenez-Juarez
ECEnna Guadalupe Villanueva Cabrera
Enna Guadalupe Villanueva Cabrera
HMHelen's Irais Sánchez Mendoza
Helen's Irais Sánchez Mendoza
In 2018, the WHO published a methodology for conducting a point prevalence survey (PPS) of antibiotic use in hospitals. The aim of this study is to report the use of antibiotics in six second-level hospitals in Mexico using this methodology. Methods: A multicenter cross-sectional study based on the 2021–2023 adaptation for Latin American hospitals was conducted in internal medicine, surgery, intensive care unit (ICU), obstetrics and gynecology and pediatrics departments of the IMSS in the western region of the state of Mexico. Results: The overall prevalence of antibiotic use was 61%; the services with the highest prevalence of prescription were general surgery (79%) and the ICU (78%). A total of 846 patients were surveyed; there were no differences in antibiotic use or non-use in terms of gender, surgical procedure and invasive devices, but there were differences in median age and comorbidities. Adherence to guidelines was 53.9%. The three main antibiotics used were third-generation cephalosporins (28%), carbapenems (13%) and glycopeptides (9%); for the type of indication, for CAI and prophylaxis, the rates of use of third-generation cephalosporins were 29.2% and 44.5%, respectively, while for healthcare-associated infections, carbapenems were used (23.9%). By AWaRe group, the watch group was predominant for all types (63.9%), for prophylaxis it was the access group (39.3%), and for HAIs it was the reserve group (4.9%).

1 July 2019 in Boletín Médico del Hospital Infantil de México
Verified
Journal Article
Closed access
PRPaola G. Rivadeneyra-Espinar
Paola G. Rivadeneyra-Espinar
GEGerman Alberto Venegas Esquivel
German Alberto Venegas Esquivel
CDClaudia M. Díaz-Espinoza
Claudia M. Díaz-Espinoza
VPVíctor M. Pérez-Robles
Víctor M. Pérez-Robles
MGMariana I. González-Fernández
Mariana I. González-Fernández
ESEduardo Sesma-Medrano
Eduardo Sesma-Medrano
Background: Although in most cases Zika is an uncomplicated febrile disease, in pregnant women is a recognized cause of congenital disorders. Microcephaly is the characteristic most frequently described in the congenital Zika virus syndrome, and the diagnosis requires laboratory confirmation. Case report: A 23-year-old female on the ninth week of pregnancy by date of last menstrual period and 10.3 weeks by ultrasound, attended to Health Services, presenting clinical manifestations of Zika infection, which was later confirmed by laboratory tests. In her 18.6 weeks of pregnancy, a non-mobile single fetus was documented. Additional findings were microcephaly, lack of thorax with cardiac activity, anterior corporal placenta with 30% calcification, and an image of probable venous lake versus placental cyst. She was admitted to the emergency room for late abortion and labor was induced, obtaining an 80 g male product with head circumference of 9 cm. Reverse transcription polymerase chain reaction analysis on the umbilical cord was positive for Zika virus. Conclusions: Zika infection during pregnancy must be suspected and diagnosed promptly to offer comprehensive care. The loss of conception in these patients has been documented with results of chorionic villus biopsies, finding Zika virus RNA and suggesting spontaneous abortion early during viremia.